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Introduction
The availability of genetically defined mouse strains, plus the abundance of bio-markers and reagents for experimentation adds to 
the value of mice as an in-vivo research tool to study wound infection and healing.  A simple and reliable full thickness murine
skin chamber is described which is suitable for use in mice with normal or depressed immune function.  We will use it to assess 
the ability of  polyclonal antibodies to provide passive immune protection from Pseudomonas aeruginosa infection, & to assess 
the effects of bacterial products on wound healing.
Results
All of the chambers remained in 
place for at least 15 days in normal 
and in immuno-compromised mice 
(Fig 4).  When chambers on normal 
mice were  inoculated with 1000 
colony forming units (cfu) of a 
clinical strain of P.aeruginosa all 
remained in place for a minimum of 
10 days, and the mice showed no 
clinical signs of infection.   
However, when chambers on 
immuno-suppressed mice were 
inoculated with the same organism, 
the mice became moribund and 
were euthanased after 3-5 days   









Fig 2: Cross section of skin chamber
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Fig 4: Chambers that remain in-situ.                     
(     ) normal female Swiss mice, (     ) female 
Swiss mice immunosuppressed on day of 
chamber implantation with 200mg/kg 


























Fig 5: Kaplan-Meier survival plot of mice which had 
their chambers inoculated with P.aeruginosa one 
day after chamber implantation. Normal mouse  
1000 cfu/mouse (    ) n = 10,   immunosuppressed
100 cfu/mouse (      ) n =5, 1000 cfu/mouse (      )  










































The chamber components are polypropylene & 
stainless steel & can be sterilised by 
autoclaving.  The assembled device weighs 1.8 
grams & has a capacity of 400µl.  The flanges 
on the chamber body provide anchorage for 
sutures, which are protected by the o-ring that 
is secured by the circlip (Fig 1). 
Chamber insertion & sampling
After anaesthesia with NembutalTM, a 10mm incision over the thorax is made through the epidermis and the flanges of the chamber 
inserted beneath the skin and seated on top of the muscle fascia.  The skin layer is repositioned over the chamber flanges and 
secured with four sutures.  The o-ring is then placed on top of the skin and secured with a circlip (Fig 2).  When sampling from the 
chamber, mice are anaesthetised with Halothane and the cap unscrewed allowing access to the interior of the chamber to remove 
samples or to inoculate with bacteria.
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Conclusion and applications
The results show that the chamber can be used in a variety of applications including bacterial infections for a period of up to 10 
days post insertion.  This device will be a useful tool to investigate many aspects of immunity, infection and healing at the skin 
surface.  The  main advantage of its design is that it permits repeated sampling, whilst containing the lesion and excluding 
environmental contamination.  Finally, this chamber should also have potential for the assessment of therapeutic agents.
